- Home
- RCKT vs KAZR Comparison
RCKT vs KAZR Comparison
Compare RCKT & KAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.18
HOLD
Current Price
$2.05
Company Overview
Basic Information| Metric | RCKT | KAZR |
|---|---|---|
| Founded | 1999 | 2024 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.2M | 398.1M |
| IPO Year | 2014 | 2024 |
Fundamental Metrics
Financial Performance| Metric | RCKT | KAZR |
|---|---|---|
| Price | $2.18 | $2.05 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $8.58 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 229.8K |
| Earning Date | 11-05-2026 | 08-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.37 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $915.60 | N/A |
| P/E Ratio | $3.58 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.18 | $1.60 |
| 52 Week High | $5.45 | $3.20 |
Technical Indicators
Market Signals| Indicator | RCKT | KAZR |
|---|---|---|
| Relative Strength Index (RSI) | 29.92 | 39.54 |
| Support Level | N/A | $1.71 |
| Resistance Level | $3.70 | $2.35 |
| Average True Range (ATR) | 0.16 | 0.23 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 5.00 | 5.79 |
Price Performance
Historical Comparison RCKT
KAZR
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.